Seek Returns

CVX vs. JNJ: A Head-to-Head Stock Comparison

Here’s a clear look at CVX and JNJ, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolCVXJNJ
Company NameChevron CorporationJohnson & Johnson
CountryUnited StatesUnited States
GICS SectorEnergyHealth Care
GICS Industry GroupEnergyPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryOil, Gas & Consumable FuelsPharmaceuticals
GICS Sub-IndustryIntegrated Oil & GasPharmaceuticals
Market Capitalization361.71 billion USD532.77 billion USD
CurrencyUSDUSD
ExchangeNYSENYSE
Listing DateJanuary 2, 1962January 2, 1962
Security TypeCommon StockCommon Stock

CVX’s market capitalization stands at 361.71 billion USD, while JNJ’s is 532.77 billion USD, indicating their market valuations are broadly comparable.

Historical Performance

This chart compares the performance of CVX and JNJ by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

CVX
JNJ
Loading price history…
CVX vs. JNJ: Growth of a $10,000 investment over the past five years.

Historical Performance at a Glance

SymbolCVXJNJ
5-Day Price Return-5.54%-1.28%
13-Week Price Return1.33%-6.93%
26-Week Price Return15.15%17.18%
52-Week Price Return32.53%42.18%
Month-to-Date Return-6.05%-3.71%
Year-to-Date Return19.17%6.94%
10-Day Avg. Volume10.26M7.17M
3-Month Avg. Volume12.31M8.36M
3-Month Volatility24.95%16.10%
Beta0.500.26

CVX’s beta of 0.50 points to significantly higher volatility compared to JNJ (beta: 0.26), suggesting CVX has greater potential for both gains and losses relative to market movements.

Profitability

Return on Equity (TTM)

CVX

7.32%

Oil, Gas & Consumable Fuels Industry
Max
28.59%
Q3
15.58%
Median
10.13%
Q1
5.19%
Min
-8.71%

CVX’s Return on Equity of 7.32% is on par with the norm for the Oil, Gas & Consumable Fuels industry, indicating its profitability relative to shareholder equity is typical for the sector.

JNJ

33.78%

Pharmaceuticals Industry
Max
41.64%
Q3
22.23%
Median
12.28%
Q1
4.84%
Min
-19.63%

In the upper quartile for the Pharmaceuticals industry, JNJ’s Return on Equity of 33.78% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

CVX vs. JNJ: A comparison of their Return on Equity (TTM) against their respective Oil, Gas & Consumable Fuels and Pharmaceuticals industry benchmarks.

Net Profit Margin (TTM)

CVX

5.92%

Oil, Gas & Consumable Fuels Industry
Max
42.70%
Q3
19.58%
Median
8.63%
Q1
3.37%
Min
-14.91%

CVX’s Net Profit Margin of 5.92% is aligned with the median group of its peers in the Oil, Gas & Consumable Fuels industry. This indicates its ability to convert revenue into profit is typical for the sector.

JNJ

21.83%

Pharmaceuticals Industry
Max
35.02%
Q3
18.96%
Median
13.68%
Q1
7.56%
Min
-8.35%

A Net Profit Margin of 21.83% places JNJ in the upper quartile for the Pharmaceuticals industry, signifying strong profitability and more effective cost management than most of its peers.

CVX vs. JNJ: A comparison of their Net Profit Margin (TTM) against their respective Oil, Gas & Consumable Fuels and Pharmaceuticals industry benchmarks.

Operating Profit Margin (TTM)

CVX

8.95%

Oil, Gas & Consumable Fuels Industry
Max
64.89%
Q3
33.58%
Median
16.60%
Q1
7.35%
Min
-31.48%

CVX’s Operating Profit Margin of 8.95% is around the midpoint for the Oil, Gas & Consumable Fuels industry, indicating that its efficiency in managing core business operations is typical for the sector.

JNJ

25.88%

Pharmaceuticals Industry
Max
43.63%
Q3
25.16%
Median
18.69%
Q1
10.76%
Min
-10.08%

An Operating Profit Margin of 25.88% places JNJ in the upper quartile for the Pharmaceuticals industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

CVX vs. JNJ: A comparison of their Operating Profit Margin (TTM) against their respective Oil, Gas & Consumable Fuels and Pharmaceuticals industry benchmarks.

Profitability at a Glance

SymbolCVXJNJ
Return on Equity (TTM)7.32%33.78%
Return on Assets (TTM)4.25%13.76%
Net Profit Margin (TTM)5.92%21.83%
Operating Profit Margin (TTM)8.95%25.88%
Gross Profit Margin (TTM)41.97%67.95%

Financial Strength

Current Ratio (MRQ)

CVX

1.15

Oil, Gas & Consumable Fuels Industry
Max
2.58
Q3
1.65
Median
1.26
Q1
0.90
Min
0.01

CVX’s Current Ratio of 1.15 aligns with the median group of the Oil, Gas & Consumable Fuels industry, indicating that its short-term liquidity is in line with its sector peers.

JNJ

1.03

Pharmaceuticals Industry
Max
6.79
Q3
3.58
Median
1.99
Q1
1.38
Min
0.71

JNJ’s Current Ratio of 1.03 falls into the lower quartile for the Pharmaceuticals industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

CVX vs. JNJ: A comparison of their Current Ratio (MRQ) against their respective Oil, Gas & Consumable Fuels and Pharmaceuticals industry benchmarks.

Debt-to-Equity Ratio (MRQ)

CVX

0.22

Oil, Gas & Consumable Fuels Industry
Max
2.25
Q3
1.07
Median
0.53
Q1
0.27
Min
0.00

Falling into the lower quartile for the Oil, Gas & Consumable Fuels industry, CVX’s Debt-to-Equity Ratio of 0.22 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.

JNJ

0.59

Pharmaceuticals Industry
Max
2.02
Q3
0.91
Median
0.29
Q1
0.06
Min
0.00

JNJ’s Debt-to-Equity Ratio of 0.59 is typical for the Pharmaceuticals industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

CVX vs. JNJ: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Oil, Gas & Consumable Fuels and Pharmaceuticals industry benchmarks.

Interest Coverage Ratio (TTM)

CVX

-5.38

Oil, Gas & Consumable Fuels Industry
Max
43.73
Q3
20.32
Median
6.70
Q1
2.81
Min
-19.25

CVX has a negative Interest Coverage Ratio of -5.38. This indicates that its earnings were insufficient to cover even its operational costs, let alone its interest payments, signaling significant financial distress.

JNJ

34.01

Pharmaceuticals Industry
Max
149.64
Q3
63.15
Median
13.00
Q1
2.46
Min
-29.59

JNJ’s Interest Coverage Ratio of 34.01 is positioned comfortably within the norm for the Pharmaceuticals industry, indicating a standard and healthy capacity to cover its interest payments.

CVX vs. JNJ: A comparison of their Interest Coverage Ratio (TTM) against their respective Oil, Gas & Consumable Fuels and Pharmaceuticals industry benchmarks.

Financial Strength at a Glance

SymbolCVXJNJ
Current Ratio (MRQ)1.151.03
Quick Ratio (MRQ)0.740.69
Debt-to-Equity Ratio (MRQ)0.220.59
Interest Coverage Ratio (TTM)-5.3834.01

Growth

Revenue Growth

CVX vs. JNJ: A comparison of their Revenue Growth across different time periods.

Revenue Growth at a Glance

SymbolCVXJNJ
Revenue Growth (MRQ vs Prior YoY)3.16%9.91%
Revenue Growth (TTM vs Prior YoY)-3.65%7.87%
3-Year Revenue CAGR-7.85%5.60%
5-Year Revenue CAGR14.32%2.67%

EPS Growth

CVX vs. JNJ: A comparison of their EPS Growth across different time periods.

EPS Growth at a Glance

SymbolCVXJNJ
EPS Growth (MRQ vs Prior YoY)-44.32%-52.82%
EPS Growth (TTM vs Prior YoY)-33.95%-3.89%
3-Year EPS CAGR-28.70%17.88%
5-Year EPS CAGR--14.90%

Dividend

Dividend Yield (TTM)

CVX

3.52%

Oil, Gas & Consumable Fuels Industry
Max
10.34%
Q3
5.13%
Median
3.45%
Q1
1.48%
Min
0.00%

CVX’s Dividend Yield of 3.52% is consistent with its peers in the Oil, Gas & Consumable Fuels industry, providing a dividend return that is standard for its sector.

JNJ

2.32%

Pharmaceuticals Industry
Max
8.08%
Q3
3.27%
Median
2.09%
Q1
0.00%
Min
0.00%

JNJ’s Dividend Yield of 2.32% is consistent with its peers in the Pharmaceuticals industry, providing a dividend return that is standard for its sector.

CVX vs. JNJ: A comparison of their Dividend Yield (TTM) against their respective Oil, Gas & Consumable Fuels and Pharmaceuticals industry benchmarks.

Dividend Payout Ratio (TTM)

CVX

103.68%

Oil, Gas & Consumable Fuels Industry
Max
192.93%
Q3
92.83%
Median
55.03%
Q1
23.70%
Min
0.00%

CVX’s Dividend Payout Ratio of 103.68% is above 100%. This means the company is paying out more in dividends than it earned, a practice that is often unsustainable and could indicate a risk to future dividend stability.

JNJ

46.19%

Pharmaceuticals Industry
Max
165.20%
Q3
80.35%
Median
44.83%
Q1
0.00%
Min
0.00%

JNJ’s Dividend Payout Ratio of 46.19% is within the typical range for the Pharmaceuticals industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

CVX vs. JNJ: A comparison of their Dividend Payout Ratio (TTM) against their respective Oil, Gas & Consumable Fuels and Pharmaceuticals industry benchmarks.

Dividend at a Glance

SymbolCVXJNJ
Dividend Yield (TTM)3.52%2.32%
Dividend Payout Ratio (TTM)103.68%46.19%

Valuation

Price-to-Earnings Ratio (TTM)

CVX

32.92

Oil, Gas & Consumable Fuels Industry
Max
43.31
Q3
26.86
Median
16.76
Q1
11.16
Min
3.31

A P/E Ratio of 32.92 places CVX in the upper quartile for the Oil, Gas & Consumable Fuels industry. This high valuation relative to peers suggests the market holds elevated expectations for the company’s future growth.

JNJ

25.32

Pharmaceuticals Industry
Max
48.06
Q3
27.48
Median
18.67
Q1
12.98
Min
3.83

JNJ’s P/E Ratio of 25.32 is within the middle range for the Pharmaceuticals industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

CVX vs. JNJ: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Oil, Gas & Consumable Fuels and Pharmaceuticals industry benchmarks.

Price-to-Sales Ratio (TTM)

CVX

1.95

Oil, Gas & Consumable Fuels Industry
Max
7.36
Q3
3.53
Median
1.86
Q1
0.79
Min
0.00

CVX’s P/S Ratio of 1.95 aligns with the market consensus for the Oil, Gas & Consumable Fuels industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

JNJ

5.53

Pharmaceuticals Industry
Max
7.30
Q3
4.66
Median
2.48
Q1
1.89
Min
0.20

JNJ’s P/S Ratio of 5.53 is in the upper echelon for the Pharmaceuticals industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

CVX vs. JNJ: A comparison of their Price-to-Sales Ratio (TTM) against their respective Oil, Gas & Consumable Fuels and Pharmaceuticals industry benchmarks.

Price-to-Book Ratio (MRQ)

CVX

1.65

Oil, Gas & Consumable Fuels Industry
Max
4.69
Q3
2.48
Median
1.50
Q1
0.98
Min
0.00

CVX’s P/B Ratio of 1.65 is within the conventional range for the Oil, Gas & Consumable Fuels industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

JNJ

6.13

Pharmaceuticals Industry
Max
10.12
Q3
5.22
Median
2.61
Q1
1.55
Min
0.63

JNJ’s P/B Ratio of 6.13 is in the upper tier for the Pharmaceuticals industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

CVX vs. JNJ: A comparison of their Price-to-Book Ratio (MRQ) against their respective Oil, Gas & Consumable Fuels and Pharmaceuticals industry benchmarks.

Valuation at a Glance

SymbolCVXJNJ
Price-to-Earnings Ratio (TTM)32.9225.32
Price-to-Sales Ratio (TTM)1.955.53
Price-to-Book Ratio (MRQ)1.656.13
Price-to-Free Cash Flow Ratio (TTM)21.8427.05